-
Aldeyra CEO Todd Brady Explains Why He Thinks Company Can Have 'Dramatic' Impact In Healthcare
Wednesday, March 9, 2016 - 4:14pm | 1307Aldeyra Therapeutics Inc (NASDAQ: ALDX) is a small-cap biotech company that specializes in the development of drugs to treat immune and inflammatory diseases. Aldeyra’s most advanced drug is an eye drop treatment for Sjogren-Larsson Syndrome. Benzinga sat down with Aldeyra CEO Todd Brady to...